Gaseovet MS

Quick links

Choose a section

Quick links to important sections

Advertisements

Gaseovet MS

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Gaseovet MS

Property Description
Active Ingredients Magaldrate and Simethicone
Form Oral Suspension and Chewable Tablet
Pharmacological Class Antacid and Anti-flatulent Agent
Common Use Relief from Hyperacidity and Flatulence
Origin Synthetic

Gaseovet MS is a synthetic, fixed-dose combination pharmaceutical product, specifically formulated for oral administration and classified as a dual-action Antacid and Anti-flatulent agent. Its core identity is defined by the combination of the antacid Magaldrate and the anti-flatulent Simethicone. This coordinated approach distinguishes Gaseovet MS from simpler, single-ingredient antacid preparations by simultaneously addressing two primary sources of gastric distress.

Composition and Dual Action

The key active components are presented either as an Oral Suspension or a Chewable Tablet. Magaldrate functions to neutralize excess gastric acid and is characterized by its capacity for sustained acid-reducing effects. This acid-neutralizing capability provides relief from the corrosive sensation of heartburn. Concurrently, Simethicone is included to mechanically relieve discomfort caused by trapped gas, acting locally within the gastrointestinal tract.

General Purpose and Differentiation

The overall purpose of Gaseovet MS is to provide rapid and comprehensive relief from symptoms associated with both hyperacidity and accumulated gas, commonly manifesting as heartburn and bloating. The combination of Magaldrate and Simethicone is used as an approach for addressing these co-occurring symptoms. This dual-action approach is particularly useful in scenarios where a patient is experiencing general digestive discomfort caused by both stomach acid and intestinal gas. As a combination, Gaseovet MS provides a practical solution for managing two distinct sources of discomfort with a single preparation, an important differentiating feature compared to taking two separate medications.

Advertisements

What side effects are possible with Gaseovet MS?

Possible Side Effects and Safety Information for Gaseovet MS

Gaseovet MS is based on an active substance that is generally considered to be physiologically inert, meaning it is not absorbed systemically into the bloodstream following oral administration. Due to this characteristic, the medication has a safety profile where serious systemic adverse reactions are not commonly associated with its use.

Officially documented adverse reactions are typically classified as uncommon. The regulatory frequency framework defines uncommon side effects as those occurring in 1 in 100 to 1 in 1,000 patients. The primary system-organ class involved is the gastrointestinal tract.


Adverse Reaction Category Frequency Classification System-Organ Class
Constipation Uncommon Gastrointestinal
Nausea Uncommon Gastrointestinal

Population-Specific and High-Level Safety Notes

No specific serious adverse reactions have been commonly reported in regulatory documentation for the active substance. The safety profile generally supports use during pregnancy and breastfeeding, as the drug is not absorbed systemically.

Safety-Related Restrictions or Limitations:

  • A potential for reduced absorption exists if the product is administered at the same time as certain other medications, such as levothyroxine, by possibly binding them in the gastrointestinal tract. This can lead to reduced efficacy of the co-administered drug.
  • To prevent this interaction, regulatory guidance typically recommends that this product be taken at least four hours before or after the interacting medication.
  • The safety profile for pediatric and geriatric populations is not specifically compared in all regulatory documents, though the drug has been tested in children and generally has not shown different side effects compared to adults.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Gaseovet MS is a name used to represent the class of medications known as H2 receptor antagonists, which include drugs like cimetidine, famotidine, and nizatidine. Overdoses with these agents are generally considered very safe, but certain symptoms indicate the need for prompt medical evaluation.

Overdose presentations reported for this class of medication can affect several physiological systems, with primary manifestations including central nervous system (CNS) effects and potential cardiovascular changes.

Documented Overdose Manifestations may include:

  • CNS effects: Confusion, agitation, slurred speech, hallucinations, and excessive drowsiness.
  • Cardiovascular effects: Abnormal heart rhythm (which may be rapid or slow heartbeat), and low blood pressure (hypotension).
  • Gastrointestinal and other effects: Nausea, vomiting, diarrhea, flushing, and in rare cases with high exposure, potential for liver effects like jaundice.

When to Seek Immediate Medical Help

Any ingestion exceeding the prescribed or recommended dose should prompt immediate medical attention. It is necessary to seek emergency care for any symptoms of overdose, particularly if you observe an abnormal heart rate, confusion, difficulty breathing, or signs of low blood pressure. Do not induce vomiting unless specifically instructed by a healthcare provider or a poison control center. Providing the exact substance name, the amount taken, and the time of ingestion to emergency personnel is critical for appropriate care.

Advertisements

Therapeutic Uses of Gaseovet MS

What Gaseovet MS Treats: Main Uses and Benefits

The primary therapeutic benefit of this combination product is its role in the symptomatic management of symptoms related to physical discomfort caused by excess acid and gas. This type of combination is used for easing symptoms like heartburn and gas that co-occur during indigestion and upset stomach.

This medication is commonly used across conditions presenting with acute episodes and recurrent episodic manifestations, including Hyperacidity, Functional Dyspepsia, Gastritis, and symptoms of Gastroesophageal Reflux Disease (GERD). It is applied when appropriate to address symptom clusters that may become intense or disruptive, such as abdominal pressure, bloating, sour stomach, and fullness.

“This approach is relevant in contexts involving heightened systemic burden, focusing on the short-term symptomatic support of co-occurring acid and gas distress.”

This dual-action support contributes to improved comfort during periods of heightened symptoms and may help support patients during symptom fluctuations.


Quick Fact: Relief for Concurrent Acid and Gas Symptoms This product is applied in clinical settings that involve acute or unstable symptom patterns, providing support that helps ease the overall symptom burden and may assist when symptoms interfere with daily functioning.

Regulatory References

  1. Health Canada's Antacid Labelling Standard
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Gaseovet MS?

The eligibility for Gaseovet MS (Magaldrate/Simethicone) is strictly defined by official regulatory documentation, focusing on specific population exclusions and restrictions.


Contraindicated Populations

Use is strictly contraindicated in several groups. This includes patients with known hypersensitivity or allergy to Magaldrate, Simethicone, or any excipients in the formulation. It is also prohibited for individuals diagnosed with severe renal impairment or kidney failure due to the risk of aluminum and magnesium accumulation. Patients with pre-existing hypophosphatemia must also avoid this medicine.


Age and Conditional Use

Regulatory bodies have established that the medicine is generally intended for Adults (18+) and Adolescents (12+). Use in children under 12 years of age is not established and not recommended without explicit physician guidance. Use during pregnancy is classified as conditional and only permitted if the potential benefit outweighs the potential risk. Caution is advised during lactation.


Condition-Based Restrictions

Patients with non-severe renal dysfunction must use the medicine under medical oversight, and prolonged use is discouraged. Conditional use also applies to those with a history of gastrointestinal issues, such as bowel obstruction or appendicitis.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The active ingredient in Gaseovet MS, Simethicone, has a generally favorable safety profile with very few known drug interactions because it is not absorbed into the bloodstream. However, a significant interaction has been documented with certain thyroid medications.

Interaction with Thyroid Preparations

Simethicone may interfere with the absorption of levothyroxine (a medication used to treat thyroid deficiency or hypothyroidism). This is considered a moderately clinically significant interaction. The proposed mechanism involves Simethicone potentially binding to or otherwise reducing the amount of levothyroxine that the body absorbs from the digestive tract. This reduction in absorption can lead to a decrease in the effectiveness of the thyroid medication.

Interacting Product Category Specific Interacting Medicine Interaction Result Recommended Management Note
Thyroid Preparations Levothyroxine (or similar thyroid hormones) Reduced absorption of levothyroxine, leading to decreased effectiveness of the thyroid treatment. Consult a healthcare provider before use; a dosing interval of at least four hours between the two medicines is often recommended to minimize this effect.

Patients taking levothyroxine for a thyroid condition are advised to consult their doctor or pharmacist before using Gaseovet MS to determine the appropriate timing for taking the products to ensure the levothyroxine remains fully effective. No other major drug-drug or drug-food interactions are consistently highlighted in authoritative regulatory summaries.

Advertisements

Mechanism of Action

How Gaseovet MS Works

Gaseovet MS utilizes two entirely independent and complementary mechanistic domains to implement its distinct pharmacodynamic mechanisms, neither of which involves systemic absorption or cellular signaling.


Targeted pH Modulation via Chemical Neutralization

This primary domain focuses on Magaldrate's direct chemical interaction with the stomach contents. Its mechanism involves the rapid buffering of gastric HCl (H^+ ions), which chemically modifies the highly acidic environment. The physiological consequence of this neutralization cascade is a local increase in intraluminal pH, reducing the corrosive burden on the gastric mucosa and decreasing the H^+-dependent stimulation of local sensory fibers.


️ Physical Alteration of Intraluminal Gas Dynamics

The secondary domain is mediated by Simethicone, which exerts a purely physical, non-chemical action on the contents of the digestive tract. Operating as a surfactant, it reduces the surface tension of liquid-gas interfaces, initiating a cascade that forces small, trapped gas bubbles to coalesce into larger gas bodies. This modulation of physical gas dynamics enables the increased probability of gas expulsion through natural orifices. The resulting change in gas configuration reduces the physical forces that cause luminal distension.

Advertisements

Dosage and Administration Information

How to Use Gaseovet MS: Administration Guidelines

The administration of Gaseovet MS (Magaldrate and Simethicone) follows specific instructions concerning the route, frequency, and preparation of the dosage forms. The medicine is intended for Oral administration only and is available as an Oral Suspension or a Chewable Tablet.


Administration Scope

Parameter Instruction
Route of Administration Oral administration only.
Standard Dosing Schedule The typical single adult dose is 5 mL to 10 mL of the suspension or 1 to 2 chewable tablets. Use is constrained by a maximum daily dose that must not be exceeded over 24 hours.
Timing in Relation to Meals Administration is scheduled after meals and at bedtime.
Preparation Requirements The oral suspension must be shaken well prior to each use. Chewable tablets must be chewed thoroughly before swallowing.
Age-Group Administration The product is generally for adults and children 12 years of age and older. Use in children under 12 requires direction from a physician.
Special Procedural Conditions The maximum daily dose is 80 mL. Use in the presence of impaired renal function is a key procedural consideration.

Resulting Procedural Structure

The usage follows a standardized administration pattern tied to specific timing constraints and procedural steps. The use is generally on an as-needed (symptomatic) basis, typically up to three to four times daily.

Step Sequence:

  • Measure the single labeled dose (5 mL to 10 mL) of the Oral Suspension after shaking the bottle well, or take the specified number of Chewable Tablets.
  • Administer the dose by mouth (orally) after a meal or at bedtime.
  • Ensure tablets are chewed completely before swallowing, or measure the liquid dose accurately.

Advertisements

Recent Clinical Evidence

Evidence for Symptomatic Relief of Hyperacidity (Antacid Component)

This section summarizes Randomized Controlled Trials (RCTs) and regulatory assessments that examined outcomes related to the antacid component on symptoms like heartburn and acid regurgitation in adult populations. Research relating to the antacid function was evaluated in studies exploring how symptoms change over time, primarily focusing on episodic manifestations. Findings describe patterns observed in studies comparing the antacid component against controls. However, the evidence is limited by the fact that the evidence derived from key studies often involves Magaldrate combined with other agents, not always Simethicone.


Evidence for Symptomatic Relief of Gas Accumulation (Anti-flatulent Component)

The anti-flatulent component was studied for outcomes related to physical discomfort caused by gas. The research landscape includes systematic reviews and controlled trials that examined outcomes regarding bloating, flatulence, and abdominal distension. Findings indicate patterns related to Simethicone observed in studies that showed changes measured during the study period for gas-related discomfort. A key limitation is that most extensive evidence relates to Simethicone used alone (monotherapy), and the applicability of all results applies only to the populations studied, requiring extrapolation for the specific fixed combination.


Research Context for Functional Dyspepsia and Research Gaps

Gaseovet MS was evaluated in research settings that address the co-occurrence of acid and gas-related outcomes often seen in general Functional Dyspepsia. The dual-action approach was applied in research contexts involving fluctuating or unstable symptoms. However, comparative evidence is lacking for the fixed combination for overall, undifferentiated functional dyspepsia. Furthermore, studies generally have follow-up durations that were limited, and research exploring long-term outcomes is not fully established. Data for certain groups, such as children or pregnant women, remain insufficient in authoritative sources.

Key Studies & References

  1. Health Canada's Antacid Labelling Standard (Nonprescription Drugs)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Gaseovet MS (FAQ)


Q: How quickly does Gaseovet MS typically start to relieve symptoms of acid or gas?

A: Gaseovet MS is known to work quickly for acid-related symptoms, as official information describes the Magaldrate component as a rapid-acting neutralizer of existing stomach acid. The Simethicone component, which helps with trapped gas, is also designed to work locally and quickly, as it is not absorbed into the bloodstream.


Q: Are there specific warnings about Gaseovet MS use for people with known kidney impairment?

A: Regulatory documents state that caution is necessary, or use may be avoided, for products containing aluminum and magnesium, like Gaseovet MS, in patients with severe renal impairment (kidney disease). This is because there is a risk that the aluminum and magnesium components could accumulate in the body when kidney function is severely reduced.


Q: Is Gaseovet MS sometimes described as having a mucosal protective action in official texts?

A: Yes, official descriptions of the Magaldrate component explain that it works to neutralize stomach acid, which reduces the harsh, corrosive burden on the gastric lining. The physiological consequence of this action is often described as creating a viscous protective barrier on the delicate mucosal surface.


Q: Is Gaseovet MS commonly prescribed for a peptic ulcer?

A: Magaldrate, one of the active ingredients in Gaseovet MS, is included in some regulatory documents as being indicated for the relief of symptoms related to hyperacidity in conditions such as peptic ulcers and gastritis. Its inclusion in the list of indications is based on its ability to neutralize the excess stomach acid that may contribute to the discomfort of these conditions.


Q: Is Gaseovet MS effective for treating symptoms of gastritis?

A: Official indications list the use of Gaseovet MS for the relief of hyperacidity symptoms associated with gastritis. Gastritis is inflammation of the stomach lining, and Gaseovet MS helps by neutralizing the acidic environment that contributes to the discomfort.


Q: Why is Gaseovet MS sometimes mentioned in relation to hiatal hernia discomfort?

A: The ingredients in Gaseovet MS, particularly Magaldrate, are commonly indicated for symptomatic relief from conditions involving acid reflux. Regulatory sources list its use for symptoms associated with gastroesophageal reflux disease (GERD) and related issues like hiatal hernia discomfort, where acid can back up into the esophagus.


Q: Are there any known long-term side effects from using Gaseovet MS regularly?

A: Official product information suggests a limit on continuous use to typically two weeks unless supervised by a healthcare provider. Use beyond this duration is monitored. Prolonged use of aluminum-containing antacids may be associated with potential changes in mineral levels, such as the reduction of phosphate in the body (hypophosphatemia).


Q: Are the most commonly reported side effects listed for Gaseovet MS?

A: Yes, the official product safety information provides a list of potential side effects. The most commonly reported issues related to the gastrointestinal system include changes in bowel habits, such as diarrhea and constipation.


Q: Is diarrhea or constipation a frequently noted side effect when using Gaseovet MS?

A: Both diarrhea and constipation are frequently noted gastrointestinal effects. The magnesium component of the drug is often associated with the potential for diarrhea, while the aluminum component may be associated with constipation.


Q: Is it possible for Gaseovet MS to cause a general allergic reaction?

A: While severe allergic reactions are rare, the product is contraindicated (should not be used) if a person has a known hypersensitivity or allergy to Magaldrate, Simethicone, or any of the ingredients in the formulation. Patients should review the full list of ingredients if they have known allergies.


Q: Can Gaseovet MS potentially interfere with the absorption of other oral medications?

A: Yes, official warnings state that Gaseovet MS has the potential to reduce or delay the absorption of other orally administered medications. This is because antacids can change the pH environment in the stomach and bind to other medicines. Taking Gaseovet MS separately from other drugs is often cited as a way to minimize this effect.


Q: Does Gaseovet MS interact with blood thinners?

A: Antacids like Gaseovet MS can interact with a wide range of oral medications. To help reduce the risk of interaction, regulatory documents recommend separating the time of administration of Gaseovet MS from other oral prescription drugs, including classes like blood thinners, by a specific time period, typically two hours.


Q: Does Gaseovet MS contain any aluminum, and is this a relevant safety consideration?

A: Yes, the Magaldrate component is a chemical complex that contains both aluminum and magnesium. The aluminum content is a safety consideration, primarily for individuals with severe kidney impairment or those who use the medication for a very long duration.


Q: Are there any known interactions between Gaseovet MS and common dietary supplements or vitamins?

A: Regulatory documents indicate that Gaseovet MS may interfere with the absorption of other oral products, which can include vitamins and certain supplements (such as iron or fluoride). To help ensure full absorption, a separation in the time of taking Gaseovet MS and supplements is generally cited in the official information.


Q: What is the official regulatory classification of Gaseovet MS (e.g., antacid, anti-flatulent)?

A: Gaseovet MS is officially classified as a combination product containing an antacid ( Magaldrate) and an anti-flatulent ( Simethicone) agent. It is intended to treat symptoms caused by both excess stomach acid and trapped gas.


Q: Where can a patient access the official product label or SmPC document for Gaseovet MS?

A: Official, comprehensive information, such as the Summary of Product Characteristics (SmPC) or the full Patient Information Leaflet (PIL), is typically published on the website of the relevant national drug authority, such as the FDA DailyMed or the EMA.


Q: What are the key themes or findings described in the research evidence for Gaseovet MS?

A: Clinical evidence themes described in official documents focus on the drug's intended actions. These typically include the Magaldrate component's proven ability to achieve effective pH neutralization and the Simethicone component's role in the successful reduction of gas and bloating symptoms.


Q: How does Gaseovet MS differ in mechanism from H2 blockers or proton pump inhibitors (PPIs)?

A: Gaseovet MS is a neutralizing antacid that works instantly to counteract existing acid in the stomach. H2 blockers and Proton Pump Inhibitors (PPIs) are different classes of medicine that work systemically to reduce or block the actual production of stomach acid within the body's cells.


Q: Does Gaseovet MS contain common allergens like gluten, lactose, or sugar?

A: Suitability regarding common allergens depends on the specific inactive ingredients (excipients) used in the formulation. The presence of ingredients like lactose, sugar, or starch that may be sources of gluten would be detailed on the official product label's list of inactive ingredients.


Q: Can Gaseovet MS alter the color or consistency of a person's stools?

A: Yes, changes to stools are listed among the possible effects. Antacids containing aluminum and magnesium salts can cause changes in bowel habits like diarrhea or constipation, and they may occasionally result in fecal discoloration.


Q: Is Gaseovet MS appropriate for use by pregnant individuals?

A: Information regarding use during pregnancy and breastfeeding is contained in the official documents, and patients are generally advised to consult a healthcare provider. Regulatory documents stress that dosages should not be excessive or used for prolonged periods in this population.


Q: Has the safety of Gaseovet MS been studied in individuals who are elderly?

A: Official product information often notes that due to potential age-related decline in kidney function, caution may be necessary when administering the medication to elderly individuals. Information regarding appropriate use in the elderly is part of the official prescribing information.


Q: Has Gaseovet MS been studied for use in children under 12?

A: The product is generally intended for patients 12 years of age and older. Use in children under 12 years of age is typically listed as requiring direction from a physician, as the safety and appropriate dosage for this young age group may not be fully established in the labeling.


Q: Is Gaseovet MS available over-the-counter or only by prescription?

A: In many regions, combination antacid and anti-flatulent products are classified as Over-the-Counter (OTC) medications. This means they are available for purchase without the need for a physician's prescription.


Q: What should be known about using Gaseovet MS if a person has liver impairment?

A: Official documents often list caution for the use of this type of medication in individuals with liver impairment (hepatic disease). Use in individuals with pre-existing conditions requires careful consideration, as described in the official product information.


Q: Do official documents mention any potential for Gaseovet MS to be habit-forming?

A: There is no evidence in official regulatory documents to indicate that Gaseovet MS, or its active ingredients Magaldrate and Simethicone, have the potential to be habit-forming or cause dependence.


Q: What are the official sources for determining if Gaseovet MS is safe for a specific age group?

A: Information on safety, contraindications, and appropriate dosage for specific age groups is documented in the official regulatory sources, such as the Summary of Product Characteristics (SmPC), the Patient Information Leaflet (PIL), or the FDA drug label.


Q: Is Gaseovet MS suitable for individuals who follow a vegetarian or vegan diet?

A: Suitability for a vegetarian or vegan diet depends entirely on the inactive ingredients (excipients) used during manufacturing. The official product label's list of excipients contains information on animal-derived components, if present, such as gelatin or certain coatings.


Q: What is the difference between Gaseovet MS and a single-ingredient antacid?

A: Gaseovet MS is a combination product that contains two active ingredients: Magaldrate for acid neutralization and Simethicone for gas/bloating relief. A single-ingredient antacid, by contrast, only contains the component necessary for neutralizing acid.


Q: Is it normal to feel a chalky taste after taking the chewable tablets?

A: Yes, a chalky taste is specifically mentioned in some official product descriptions as a commonly reported experience associated with taking the medication. This is usually due to the composition and texture of the tablet form.


Q: Is Gaseovet MS considered a first-line treatment for acid reflux?

A: Gaseovet MS is indicated for the symptomatic relief of heartburn and acid indigestion, which addresses the symptoms of mild, occasional acid reflux. This classification is based on its mechanism of action as a neutralizing antacid.


Q: Does Gaseovet MS interact with commonly used pain relievers, such as ibuprofen or aspirin?

A: Antacids can affect how the body absorbs many different oral medications, including common pain relievers. Official documents recommend separating the administration of Gaseovet MS from other oral medications, often by a period of two hours, to help reduce the potential for interaction.

Advertisements

How should Gaseovet MS be stored and disposed of?

How to Store and Dispose of Gaseovet MS?

Regulatory labeling establishes mandatory requirements for the storage and disposal of this Magaldrate and Simethicone combination product.


Storage Requirements

Gaseovet MS must be stored at controlled room temperature, typically defined as below 30 C. It is explicitly instructed not to refrigerate or freeze the medication, particularly the oral suspension, to prevent stability issues.

Keep the product in its original container and ensure the container is tightly closed to provide protection from excess moisture and light. Furthermore, the medicine must be stored in a location that is always out of the sight and reach of children.

Disposal Instructions

Unused or expired Gaseovet MS must be disposed of in accordance with local pharmaceutical waste regulations. To prevent environmental contamination, the product should not be flushed down a toilet or poured into a sink unless specifically authorized by the labeling or a public authority. The preferred method for discarding is often through official drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gaseovet MS found in:

A-Z Index: